Effects of linagliptin on diabetic nephropathy in CKD patients
Not Applicable
- Conditions
- patients with diabetic nephropathy
- Registration Number
- JPRN-UMIN000010952
- Lead Sponsor
- Kurume University School of Medicine
- Brief Summary
There was no evidence of the benefit of torazenta.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) diabetic ketoacidosis 2) severe infection 3) pregnancy 4) CHF, AKI 5) severe liver dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method